Endovia Health Sciences, Inc.
EDVA · XNYSCIK 1553788fmd_0J7JV3ZN4H0JVM5ANGY16XH4PNManufacturing · BeveragesTemplate: Standard
Coverage: Jan 01, 2011 to Jun 30, 2026, 59 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 1 | 1 | 1 | – | 2 | 11 | 18 | 19 | – | 0 |
| Cost of revenue | 0 | 0 | 1 | 0 | 2 | 7 | 12 | 13 | 4 | – |
| Net interest income | – | – | – | (1) | (2) | (0) | – | (2) | (4) | (3) |
| Gross profit | 1 | 0 | 1 | (0) | 0 | 4 | 6 | 6 | (0) | 0 |
| Selling, general and administrative | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
| Total operating expenses | 1 | 1 | 1 | 4 | 18 | 33 | 27 | 21 | 10 | 14 |
| Operating income | (0) | (0) | 0 | (4) | (18) | (29) | (21) | (15) | (10) | (14) |
| Interest expense | 0 | 0 | 0 | 0 | – | 0 | 0 | 2 | 4 | 3 |
| Interest and investment income | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – |
| Other non-operating income (expense) | 0 | 0 | 0 | (1) | (2) | (0) | (0) | (6) | (8) | (10) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | – | – | – | (5) | (20) | (29) | (22) | (21) | (24) | – |
| Net income | (0) | (0) | 0 | (5) | (29) | (29) | (22) | (21) | (24) | (25) |
| Net income to common shareholders | – | – | 0 | (0) | (29) | (29) | (22) | – | (24) | (26) |